Systemic lupus erythematosus and pregnancy
Download
1 / 12

Systemic Lupus Erythematosus and Pregnancy - PowerPoint PPT Presentation


  • 83 Views
  • Uploaded on

Systemic Lupus Erythematosus and Pregnancy. Andres Quiceno, MD Rheumatology. Case Presentation 28 y/o WF with PMHx of SLE diagnosed in 1993 when presented with thrombocytopenia, arthritis, malar rash and +ANA. Patient was clinically in remission for the last 2 years on Plaquenil.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Systemic Lupus Erythematosus and Pregnancy' - aiko-mathews


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Systemic lupus erythematosus and pregnancy

Systemic Lupus Erythematosus and Pregnancy

Andres Quiceno, MD

Rheumatology


  • Case Presentation

  • 28 y/o WF with PMHx of SLE diagnosed in 1993 when presented with thrombocytopenia, arthritis, malar rash and +ANA.

  • Patient was clinically in remission for the last 2 years on Plaquenil.

  • On 9/30/2004 she was evaluated in a routine visit and petechiae were noted in her lower extremities. Patient stated at that time that she was trying to become pregnant.



  • Clinical Course

  • 10/4/04 Platelet count 317K, prednisone decreased to 20 mg PO QD.

  • 10/13/04 Platelet count 10K, patient admitted to the hospital, treated with methyl-prednisolone 1 gr IV x 3 and IVIG 1gr/kg/day x 2. Patient was started on azathioprine 50 mg a day. Urine pregnancy test was negative. Instructed to avoid pregnancy because SLE flare.


  • 11/2/04 Patient evaluated because 24 hrs nausea, vomiting and abdominal pain.

  • Patient no missing her period and she denied any sexual encounter since her last admission.

  • Patient sent to the ER for hydration.

  • Pregnancy test ordered there was positive.

  • Beta HCG 11824 U (7-12 weeks pregnancy). Platelet count 32K.

  • Prednisone increased to 100 mg a day.


  • 12/16/04 Admitted to high risk pregnancy service because BP 160/100 and +2 protein in U/A. 14 weeks pregnancy.

  • 24 hrs urine collection 1700 mg. Creat 0.5. Platelet 342K. SSA/SSB negative.

  • dsDNA 130, C3 and C4 within normal limits.

  • Patient received treatment with azathioprine 200 mg a day, labetalol 100 mg BID and prednisone 80 mg a day.


  • Pregnancy and flares of SLE 160/100 and +2 protein in U/A. 14 weeks pregnancy.

  • It is not clear if flares of SLE are more frequent during pregnancy.

  • Lupus flares during pregnancy do not seem to be more serious than those occurring in non-pregnant patients.

  • Lupus may flare at any trimester and the postpartum period.

  • Postgrad Med J.2001:157-165.


  • Obstetric and fetal outcome in lupus prengancy 160/100 and +2 protein in U/A. 14 weeks pregnancy.

  • The incidence of pre-eclampsia is increased.

  • Pre-existing hypertension, nephritis and presence of aPL are risk factors for pre-eclampsia.

  • Fetal wastage, prematurity and intrauterine growth retardation are more common.

  • Active nephritis at conception and the presence of aPL are predictors of fetal loss.

  • Postgrad Med J.2001:157-165.


  • Congenital heart block 160/100 and +2 protein in U/A. 14 weeks pregnancy.

  • Having SLE per se is not an independent risk factor.

  • The risk depends solely in the presence of anti-SSA/Ro or SSB/La.

  • The risk is approximately 7% in SLE mothers with positive anti-SSA/Ro.

  • Postgrad Med J.2001:157-165.


  • Use of medications in lupus pregnancies 160/100 and +2 protein in U/A. 14 weeks pregnancy.

  • NSAIDs should be avoided in the last few weeks of pregnancy.

  • Corticosteroids and hydroxychloroquine have not been shown to be teratogenic.

  • Azathioprine and cyclosporine can be used in pregnancy when intense immunosupression is necessary.

  • Cyclophosphamide is teratogenic and should be avoided.

  • Postgrad Med J.2001:157-165.


  • Lupus and Lactation 160/100 and +2 protein in U/A. 14 weeks pregnancy.

  • Big doses of aspirin should be avoided in nursing mothers.

  • NSAIDs are contraindicated in nursing mothers with jaundiced neonates.

  • Prednisone, prednisolone and hydroxychloroquine are compatible with breast feeding.

  • Breast feeding should be avoided by mothers on cytotoxic medications.

  • Postgrad Med J.2001:157-165.


  • Contraception in SLE patients. 160/100 and +2 protein in U/A. 14 weeks pregnancy.

  • Low dose estrogen contraceptives can be used in patients with stable disease and no history of thromboembolism.

  • Barrier methods or progestogens are alternatives in patients with contraindications to steroids.

  • Intrauterine contraceptive device is associated with an increase risk of infections.

  • Postgrad Med J.2001:157-165.


ad